NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15342020

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides novel, stable lipid particles having a non-lamellar structure and comprising one or more active agents or therapeutic agents, methods of making such lipid particles, and methods of delivering and/or administering such lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) that have a non-lamellar structure and that comprise a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARBUTUS BIOPHARMA CORPORATION100-8900 GLENLYON PARKWAY BURNABY BRITISH COLUMBIA V5J 5J8

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
JEFFS, LLOYD B Delta, CA 18 656
PALMER, LORNE R Vancouver, CA 34 2871
YAWORSKI, ED Maple Ridge, CA 22 783

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation